Head trauma is a leading cause of trauma related morbidity and mortality worldwide. Tranexamic acid (TXA) inhibits fibrinolysis and can decrease ongoing hemorrhage. In the CRASH-2 Trial, TXA given within 3 hours of injury was shown to decrease mortality from major extracranial injury (CRASH 2 Investigators,
Read More
Tagged ‘Neurosurgery’
Journal Review
Effects of Tranexamic Acid on Death, Disability, Vascular Occlusive Events and Other Morbidities in Patients with Acute Traumatic Brain Injury (CRASH-3): A Randomised, Placebo-Controlled Trial
Core
Cauda Equina Syndrome
This post reviews the rare but high-associated morbidity diagnosis of cauda equina syndrome.
Read More
Core
Spinal Epidural Hematoma
This post discusses the rare spinal epidural hematoma focusing on presentation and diagnosis.
Read More